[PDF] Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. | Semantic Scholar (2024)

Skip to search formSkip to main contentSkip to account menu

Semantic ScholarSemantic Scholar's Logo
@article{Tokushige2007EffectsOT, title={Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.}, author={Hideki Tokushige and Masaru Inatani and Shingo Nemoto and Hideyuki Sakaki and Koushirou Katayama and Masayoshi Uehata and Hidenobu Tanihara}, journal={Investigative ophthalmology \& visual science}, year={2007}, volume={48 7}, pages={ 3216-22 }, url={https://api.semanticscholar.org/CorpusID:9454042}}
  • H. Tokushige, M. Inatani, H. Tanihara
  • Published in Investigative Ophthalmology… 1 July 2007
  • Medicine

Y-39983 ophthalmic solution may be a candidate drug for lowering of intraocular pressure (IOP), since it increases conventional outflow and produces relatively few side effects.

172 Citations

Highly Influential Citations

5

Background Citations

48

Results Citations

3

Figures and Tables from this paper

  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6

172 Citations

Effects of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Blood Flow in Optic Nerve Head in Rabbits and Axonal Regeneration of Retinal Ganglion Cells in Rats
    H. TokushigeM. WakiY. TakayamaH. Tanihara

    Medicine

    Current eye research

  • 2011

Y-39983 may be a candidate drug not only for lowering of IOP but also for increasing of blood flow in ONH in the treatment of glaucoma, although improvements of formulation or route of administration are needed in order to reach an effective concentration in retina.

  • 62
Effects of K-115, a Rho-Kinase Inhibitor, on Aqueous Humor Dynamics in Rabbits
    Tomoyuki IsobeK. MizunoYoshio KanekoMasayuki OhtaT. KoideS. Tanabe

    Medicine

    Current eye research

  • 2014

Results indicated that K-115 ophthalmic solution, a selective and potent ROCK inhibitor, is a novel and potent antiglaucoma agent.

  • 91
  • Highly Influenced
Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK.
    N. WhitlockB. Harrison D. Rice

    Biology, Medicine

    Journal of ocular pharmacology and therapeutics…

  • 2009

The magnitude of IOP reduction is significant as demonstrated with comparative pharmacology using agents that lower IOP in humans, and support the ROCK pathway as a therapeutic target for treating ocular hypertension.

  • 41
Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries
    Hiroshi WatabeSanae AbeT. Yosh*tomi

    Medicine

    Japanese Journal of Ophthalmology

  • 2011

It is concluded that Y-27632 and Y-39983 relaxed isolated rabbit ciliary artery segments in vitro, and the mechanism of relaxation was not dependent on endothelial-derived factors such as nitric oxide (NO) or prostacyclin, nor was it dependent on changes in intracellular Ca2+ concentration.

  • 36
AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
    S. Van de VeldeT. Van Bergen I. Stalmans

    Medicine

  • 2014

AMA0076 is a locally acting ROCK inhibitor that is able to induce altered cellular behavior of HTM cells that effectively reduces IOP in ocular normotensive and acute hypertensive rabbits without causing distinct hyperemia.

  • 82
  • PDF
The Effect of the H-1152P, a Potent Rho-Associated Coiled Coil-Formed Protein Kinase Inhibitor, in Rabbit Normal and Ocular Hypertensive Eyes
    M. NishioT. f*ckunaga Y. Uji

    Medicine

    Current eye research

  • 2009

Topical administration of H-1152P potently decreased rabbit normotensive IOPs in a dose-dependent manner, and the duration of the IOP lowering was also elongated in a doses dependent manner, suggesting that H- 1152P could be a candidate for the next generation of glaucoma therapy.

  • 39
A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia.
    Cherng-Ru HsuYi-Hsun Chen D. Lu

    Medicine

  • 2019

I-E-212 is a novel and highly specific ROCK2 inhibitor with the ability to lower IOP in animal models and has favorable pharmaco*kinetic and ocular tolerability profiles with only minimal conjunctival hyperemia.

  • 15
  • PDF
Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
    M. HonjoH. TaniharaT. KamedaT. KawajiN. YoshimuraM. Araie

    Medicine

  • 2007

Y-27632 had profound effects on activities of HTFs and was effective in preventing fibroproliferation and scar formation in a rabbit model of glaucoma surgery and a ROCK inhibitor may be an effective anti-scarring agent after glAUcoma filtering surgery.

  • 128
  • PDF
The effect of Rho-associated protein kinase inhibitor on monkey Schlemm's canal endothelial cells.
    T. KamedaToshihiro Inoue H. Tanihara

    Medicine

  • 2012

Y-27632 increased the permeability of the SCE-cell monolayer in association with disruption of the tight junction, F-actin depolymerization, and changes in various cell functions, including calcium transfer.

  • 93
  • PDF
The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate.
    John J. ArnoldMark S. Hansen P. Challa

    Medicine

  • 2013

It is anticipated that care in order and timing of ROCK inhibitor administration will be warranted for those patients who may be on a multiple topical drug regimen for primary open-angle glaucoma.

  • 26
  • PDF

...

...

42 References

Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
    M. HonjoH. Tanihara Yoshihito Honda

    Medicine

  • 2001

In vitro experiments suggest that the IOP-lowering effects of Y-27632 may be related to the altered cellular behavior of TM cells and relaxation of CM contraction, and suggest that ROCK inhibitors may have great potential to be developed for treatment of glaucoma and other ocular diseases.

  • 380
  • Highly Influential
Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes.
    Megumi HonjoM. Inatani H. Tanihara

    Medicine

    Archives of ophthalmology

  • 2001

The results of in vitro experiments suggest that the IOP-lowering effects of HA1077 may be related to the altered cellular behavior of TM cells and relaxation of CM contraction, and have the potential to be developed into a treatment modality for glaucoma.

  • 115
  • PDF
Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase
    M. WakiY. YoshidaT. OkaM. Azuma

    Medicine

    Current eye research

  • 2001

The ROCK inhibitor reduced intraocular pressure in rabbits by topical instillation and relaxed the excised ciliary muscle which was previously constricted by carbachol suggesting that the inhibitor acts to increase the uveoscleral outflow.

  • 100
Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
    P. RaoPeifeng DengJ. KumarD. Epstein

    Medicine

  • 2001

PURPOSEThe goal of this study was to investigate the role of Rho kinase in the modulation of aqueous humor outflow facility. Rho kinase, a critical downstream effector of Rho GTPase is recognized to

  • 420
Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys.
    B. TianRong-Fang WangS. PodosP. Kaufman

    Medicine

    Archives of ophthalmology

  • 2004

Five percent H-7 increases outflow facility and decreases IOP, but does not affect corneal thickness, in monkeys with laser-induced unilateral glaucoma and multiple doses induce greater reduction of IOP than a single dose.

  • 23
  • PDF
Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork.
    R. RosenthalL. Choritz H. Thieme

    Medicine

    Experimental eye research

  • 2005
  • 68
H-7 disrupts the actin cytoskeleton and increases outflow facility.
    B. TianP. KaufmanT. VolbergB. GabeltB. Geiger

    Biology, Medicine

    Archives of ophthalmology

  • 1998

H-7 increases outflow facility in monkeys, probably by inhibiting cell contractility, cytoskeletal support, and cell-cell adhesions in the trabecular meshwork.

  • 131
  • PDF
Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits.
    Toru TaniguchiM. S. R. HaqueKazuhisa SugiyamaNobuhide HoriYoshiaki Kitazawa

    Medicine

    Journal of ocular pharmacology and therapeutics…

  • 1996

Unoprostone lowers the IOP by affecting aqueous outflow pathways, primarily the pressure-dependent conventional pathway and the secondary uveoscleral outflow pathway in rabbits.

  • 80
Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility.
    K. TakaishiTakuya Sasaki Y. Takai

    Biology, Medicine

    Oncogene

  • 1994

Results indicate that both rho p21 and rho GDI, but neither rac p21 nor ras p21, are involved in the HGF-induced cell motility.

  • 205
Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility.
    Priyatham S. MettuPeifeng DengU. K. MisraG. GawdiD. EpsteinP. Rao

    Biology, Medicine

  • 2004

These studies demonstrate that LPA and S1P, the physiological agonists of Edg receptors, decrease outflow facility in perfused porcine eyes in association with increased MLC phosphorylation and Rho guanosine triphosphatase (GTPase) activation.

  • 95
  • PDF

...

...

Related Papers

Showing 1 through 3 of 0 Related Papers

    [PDF] Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. | Semantic Scholar (2024)

    FAQs

    What are the side effects of rho kinase inhibitors? ›

    All in all, adverse events associated with ROCK inhibitors include conjunctival hyperemia, conjunctival hemorrhage, cornea verticillata, conjunctivitis, and blepharitis.

    What are the effects of rho associated protein kinase inhibitor y 27632 on intraocular pressure and outflow facility? ›

    conclusions. Administration of Y-27632 caused a reduction in IOP and an increase in the outflow facility.

    How do rho kinase inhibitors reduce IOP? ›

    A much smaller portion (approximately 20%) reported corneal verticillata, instillation site pain, and conjunctival hemorrhages. Rho kinase inhibitors help lower IOP by increasing AH outflow, reducing AH production, and decreasing episcleral venous pressure (EVP) [36].

    How do rho kinase inhibitors work? ›

    A Rho kinase inhibitor produces relaxation by 'calcium desensitization' [24]. Figure 2 shows that myosin light chain phosphatase is a target of the Rho/ROCK pathway. Inhibition of Rho kinases reduces myosin light chain phosphorylation thus producing relaxation.

    What are the side effects of protein kinase inhibitors? ›

    However, KIs have important side effects, including fatigue, hypertension, rash, impaired wound healing, myelosuppression, and diarrhea (14). The overall toxicity of KIs, although less life-threatening than conventional cytotoxic chemotherapy, nevertheless is common and may require dose reduction.

    What are the long term side effects of tyrosine kinase inhibitors? ›

    Those treatment side effects may range from mild skin rashes to life-threatening skin issues like Steven-Johnson syndrome/toxic epidermal necrosis. Another group of TKIs that target non-small lung cancer and colorectal cancer may cause cardiovascular issues like high blood pressure (hypertension) and proteinuria.

    What are the side effects of protein inhibitors? ›

    Common side effects of protease inhibitors
    • Abdominal pain.
    • Nausea and vomiting.
    • Diarrhea.
    • Rash.
    • Cough.
    • Fatigue.
    • Kidney stones.
    • Redistribution of fat on your body (lipodystrophy).

    What are the side effects of enzyme inhibitor? ›

    In general, the most common side effects for almost all ACE inhibitors include:
    • Dry cough. This is possible with all ACE inhibitors. For some people, it may go away. ...
    • Dizziness. This is common with all blood pressure medications. ...
    • Headache.
    • Drowsiness.
    • Feeling fatigued.
    • Weakness.
    Oct 22, 2021

    What is the function of the rho associated protein kinase? ›

    Rho-associated kinase (Rho-kinase/ROCK/ROK) is an effector of the small GTPase Rho and belongs to the AGC family of kinases. Rho-kinase has pleiotropic functions including the regulation of cellular contraction, motility, morphology, polarity, cell division, and gene expression.

    What exercise lowers IOP? ›

    Studies show that you can lower your intraocular pressure, or IOP, by doing exercises that raise your pulse by only twenty percent. You can do that easily with a twenty-minute walk, four times a week. If the weather outside is frightful, simple indoor calisthenics or yoga can do the trick, too!

    Why does IOP increase in eyes? ›

    It arises when fluid doesn't drain out of the eye at its regular rate, resulting in a buildup that increases intraocular (within the eye) pressure. Ocular hypertension may be an early sign of glaucoma, an eye disease that can cause irreversible vision loss over time if it is not treated.

    What are the eye drops for Rho-kinase? ›

    Two commonly used RKIs are Ripasudil (K-115) and Netarsudil(AR-13503). Ripasudil has been clinically approved to treat glaucoma in Japan. Side effects of Ripasudil include dose-dependent conjunctival hyperemia and non-dose dependent conjunctival hemorrhage. It has not shown any other ophthalmological side effects.

    Are rho kinase inhibitors approved by the FDA? ›

    Rho kinase (ROCK) inhibitors, a novel class of drugs approved by the American Food and Drug Administration (FDA) in 2017, act directly on TM cells to reduce intraocular pressure (IOP) [11,12].

    What does Rho-kinase do in the heart? ›

    The RhoA/Rho-kinase pathway is now widely known to play important roles in many cellular functions, including contraction, motility, proliferation, and apoptosis, and its excessive activity induces oxidative stress and promotes the development of cardiovascular diseases.

    How does Rho protein work? ›

    The E. coli Rho factor is a hexameric protein required for transcription termination at certain cytosine-rich sites (reviewed in [33,34]). When bound to nascent RNA, Rho translocates towards the 3′ end until it reaches the transcription complex, where it unwinds the RNA–DNA duplex using ATP as an energy source [35].

    What are the risk of serious adverse effects with Janus kinase inhibitors? ›

    These side effects include cardiovascular conditions, blood clots, cancer and serious infections..

    Are Janus kinase inhibitors safe? ›

    In Sept, 2021, the FDA expanded their safety warnings to the JAK inhibitor class. Similarly, in Nov, 2022, the EMA updated their recommendation on JAK inhibitors, suggesting they should only be prescribed in patients at high risk if no suitable alternatives are available—a devastating blow to many patients.

    What are the side effects of anti D rho immunoglobulin monoclonal? ›

    Serious side effects
    • Bloody urine.
    • decreased frequency of urination or amount of urine.
    • fever.
    • increased blood pressure.
    • increased thirst.
    • lower back pain.
    • nausea or vomiting.
    • pale skin.
    Aug 10, 2023

    What are the side effects of renin inhibitors? ›

    Severe hypotension (low blood pressure) Dizziness. Headache. Angioedema (accumulation of fluid cause swelling of the area below the skin or mucosa)

    References

    Top Articles
    Latest Posts
    Article information

    Author: Delena Feil

    Last Updated:

    Views: 6424

    Rating: 4.4 / 5 (45 voted)

    Reviews: 92% of readers found this page helpful

    Author information

    Name: Delena Feil

    Birthday: 1998-08-29

    Address: 747 Lubowitz Run, Sidmouth, HI 90646-5543

    Phone: +99513241752844

    Job: Design Supervisor

    Hobby: Digital arts, Lacemaking, Air sports, Running, Scouting, Shooting, Puzzles

    Introduction: My name is Delena Feil, I am a clean, splendid, calm, fancy, jolly, bright, faithful person who loves writing and wants to share my knowledge and understanding with you.